FIELD: medicine. SUBSTANCE: agent is made as tablet consisting of core that contains mexidol (16.7-41.6 weight %) and polymeric envelope. Core has the following means, weight %: white clay 16.7-33.3; potato starch 16.7-33.7; calcium stearate 0.3-0.5; stearic acid 0.3-0.5; talc 0.5-1.0, and methylcellulose 0.3-0.5. Polymeric envelope is made of methylcellulose (25-50 weight %) with addition of Tween-80 8.3-25.0 weight % and titanium dioxide 8.3-25.0 weight %. EFFECT: broad spectrum of therapeutic action, expressed antistress and antiamnestic effect. 7 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| DRUG SHOWING ANXIOLYTIC, ANTIALCOHOLIC AND CEREBROPROTECTIVE EFFECTS | 1999 |
|
RU2145855C1 |
| SYNERGETIC PREPARATION FOR TREATING CARDIOVASCULAR DISEASES, DIABETES MELLITUS AND HEPATOBILIARY DISEASES | 2012 |
|
RU2493841C1 |
| COMPOSITION OF 3-OXY-6-METHYL-2-ETHYLPYRIDINE OR ITS PHARMACEUTICALLY ACCEPTABLE SALT IN TABLETTED FORM, METHOD FOR MAKING THEREOF, AND THERAPY | 2007 |
|
RU2384330C2 |
| WATER-SOLUBLE SALAMIDE DERIVATIVE POSSESSING TRANQUILISING, NOOTROPIC AND ANALGESIC ACTIVITY | 2012 |
|
RU2540464C2 |
| N-(4-ACETOXYBENZOYL)GLYCINE LITHIUM SALT POSSESSING TRANQUILISING AND NOOTROPIC ACTION | 2012 |
|
RU2505294C1 |
| PHARMACEUTICAL COMPOSITION CONTAINING ETHYLMETHYLHYDROXYPYRIDINE SUCCINATE | 2021 |
|
RU2798106C1 |
| CEREBRAL PROTECTIVE AND STRESS-PROTECTIVE MEDICINAL AGENT "NOOTRIL" AS INJECTION SOLUTION | 2003 |
|
RU2268711C2 |
| GAMMA-AMINOBUTYRIC ACID DERIVATIVE, HAVING NOOTROPIC ACTIVITY COUPLED WITH TRANQUILISING ACTIVITY | 2012 |
|
RU2495866C1 |
| REMEDY POSSESSING NOOTROPIC AND ADAPTATION PROPERTIES AND METHOD FOR PRODUCING THE REMEDY | 1996 |
|
RU2130314C1 |
| 2-ETHYL-6-METHYL-3-HYDROXYLIRIDINIUMHYDROXYBUTANEDIOAT EXPRESSING ANTI-ISHEMIC, CEREBROPROTECTIVE, NEUROTROPIC AND LIPID-REGULATING ACTIVITY, PHARMACEUTICAL COMPOSITIONS AND MEDICAL PRODUCT | 2008 |
|
RU2377237C1 |
